Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.
Modern antivirals can cure 95% of people with HCV, lowering the risk of cirrhosis, liver cancer and liver failure.
Funding will support research on conditions including fatty liver disease, liver cancer, asthma and chronic kidney disease.
Older people, men and people living in poverty and lacking private insurance were more likely to have active HCV infection.
The CDC estimates that 21% of people living with HIV also have hepatitis C virus.
However, liver cancer mortality has risen for both Latino men and women.
Drug-related mortality, including overdose, was the leading cause of death.
In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.
About 40% of people worldwide are not aware that viral hepatitis is a leading cause of liver cancer.
Viral hepatitis could kill more people than malaria, tuberculosis and HIV combined if trends continue.
Men, people with obesity and people who smoke are more likely to develop NAFLD.
Lean people had a higher mortality rate despite experiencing fewer metabolic problems.
A “jarringly low” proportion of people with HCV have been tested, treated and cured.
However, deaths due to liver cancer in men and lung cancer in women are increasing in most countries.
Accelerated progress is needed to achieve Cancer Moonshot goal of cutting the age-adjusted cancer death rate by at least 50% over 25 years.
Human papillomavirus and hepatitis B vaccines lower the risk of developing cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.